国家医保谈判政策对公立医院谈判抗癌药物使用的影响数据

数据集获取（Figshare）

• 源站标题：Table 3_Effect of the national reimbursement drug list negotiation policy on utilization of negotiated anticancer drugs in Chinese public hospital: a quasi-natural experiment.xlsx
• DOI：10.3389/fpubh.2025.1662346.s003
• 发布日期：2025-12-12
• 文件数：1 个
• 文件总体积：11.56 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_3_Effect_of_the_national_reimbursement_drug_list_negotiation_policy_on_utilization_of_negotiated_anticancer_drugs_in_Chinese_public_hospital_a_quasi-natural_experiment_xlsx/30867566

命令行下载

curl -L -o "Table 3_Effect of the national reimbursement drug list negotiation policy on utilization of negotiated anticancer drugs in Chinese public hospital: a .xlsx" "https://ndownloader.figshare.com/files/60308825"

文件清单

• Table 3_Effect of the national reimbursement drug list negotiation policy on utilization of negotiated anticancer drugs in Chinese public hospital: a .xlsx（11.56 KB）

文件总体积 11.56 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

BackgroundHigh prices have limited access to targeted anticancer drugs in China. In 2017, 18 such drugs were added to the National Reimbursement Drug List (NRDL) through national price negotiation.
MethodMonthly hospital procurement data (2015–2019) from 887 public hospitals across 30 provinces were analyzed. Drug utilization was measured by expenditures and defined daily doses (DDDs). A difference-in-differences (DID) model and interrupted time series (ITS) analysis were employed to estimate policy effects.
ResultsFollowing policy implementation, total DDDs of negotiated drugs rose 4.03-fold and expenditures 3.07-fold, both exceeding cancer incidence growth. DID analysis confirmed significant increases for Western medicines (+479,100 DDDs; p The NRDL negotiation substantially improved access to targeted anticancer therapies in public hospitals while containing cost growth. These findings highlight the effectiveness of centralized price negotiation in expanding coverage and equity of high-cost cancer treatments in resource-constrained settings.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fpubh.2025.1662346.s003（source: https://frontiersin.figshare.com/articles/dataset/Table_3_Effect_of_the_national_reimbursement_drug_list_negotiation_policy_on_utilization_of_negotiated_anticancer_drugs_in_Chinese_public_hospital_a_quasi-natural_experiment_xlsx/30867566）。